Keywords: amylin, losses, down, 3rd-qtr, san, diego, usa-based

Amylin's losses down 37% in 3rd-qtr

Article | 30 October 2006

Print This

San Diego, USA-based drugmaker Amylin Pharmaceuticals says that it saw losses of $46.1 million, or $0.36 per share, in the third quarter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in